September 3, 2010 (FinancialWire) (Investrend Information Syndicate) (Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s featured news.) — Last month LightPath Technologies, Inc. (LPTH) announced the company’s fourth quarter results for fiscal year 2010 (ended June 30, 2010). In that announcement LightPath noted a revenues increase of 75% to $2.8 million, marking a fourth consecutive quarter of revenue growth.

Subsequent to that announcement, LightPath will host a conference call on September 16th, to discuss the company's fourth quarter financial and operational results in detail A replay of the call will be available approximately three hours after completion through September 23, 2010. FinancialWire(tm) will provide details as that broadcast date approaches.

Since announcing its fiscal Q4 results, LightPath has been noticed by various financial publications and portals. The company has been listed among the top rebounding U.S. stocks, best Performing U.S. stocks, top rising stocks with unusual volume at NASD.com (http://www.nasd100.com/), as well as being identified on a number of other financial portals’ top 100 stocks with noteworthy trading volume.

StockMarketWatch.com (http://thestockmarketwatch.com/) has taken note of LightPath’s “great growth with Increasing stock price”, noting a number of highlights in-particular, including: eight U.S. patents issued by the company (with others pending); a strong backlog of business (as of June 30, 2010, backlog totaled $2.9 million, up 30% as compared one year ago); the targeting of multiple verticals ( with products are sold to over 4,000 customers across high-growth markets in the medical, industrial, defense, tele/data communications, and sensing fields); a focus on low-cost, high-margin production (successfully reducing costs by shifting 85% of its total production to China, which has resulted in boosting gross margins from 25% to 47% in the most recent quarter); scalable production ( with production in Shanghai, China currently at 48% capacity, which can be expanded with minimal additional costs to meet rising demand in Asia); a large market opportunity as a high-volume, low-cost producer of glass aspherics (LightPath addresses a market projected to exceed $1.5 billion in the next five years, driven by growth in digital still cameras, laser projectors and thermal imaging products); experienced leadership (noting that key executives have over 60 years of combined experience in leading publicly traded companies to success in the electronics and optical industries); and, with demand for aspheric lens in Asia expected to top $280 Million by 2011, LightPath`s precision molded optics product line, particularly low cost lenses, can deliver substantial sales upside potential.

More about LPTH: Other FinancialWire(tm) news about LightPath is accessible via The FinancialWire(tm) search function (at http://www.financialwire.net/?s=lpthnas), additional information and independent research on LightPath is available via Investrend Syndications (at http://www.investrend.com/synd0003), and official information and company filings from LightPath are accessible via the SEC website (at http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001366669).

Financialwire(tm)’s “On The Radar” news beat features fundamentals-supported articles about lesser-capitalized public companies that are newly-listed and/or are making efforts toward being recognized. FinancialWire(tm)’s primary criteria for presenting these news articles includes avoiding hyperbole and including references to material information, in order to better serve shareholders and investors. FinancialWire(tm) is not compensated in any way by subject companies and/or any representatives of subject companies.

=========

Equity research on any public company is available through the Shareholders Research Alliance (go to http://www.investrend.com/synd0004 for more information).  Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html).  Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[ssryrsyr] [pltfrm] [lpthnas] [synd0003] [bsdarrgnmnt] [grdnstscrts] [ndstrls] [mnfctrng] [ndstrlspplssrvcs] [tchnlgy] [advnctchnlgy] [biomedphrm] [ftrdnwswnd] [nthrdrdrht]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.